We've found
2,627 High Blood Pressure (Hypertension)
clinical trials
Pulmonary Arterial Hypertension Clinical Trial
The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study
Status: Enrolling,
Phase
IV
Updated: 3/1/2016
Click here to add this to my saved trials
Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Clinical Trial
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling,
Phase
II
Updated: 3/3/2016
Click here to add this to my saved trials
Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Clinical Trial
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling,
Phase
II
Updated: 3/3/2016
Click here to add this to my saved trials
Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Clinical Trial
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling,
Phase
II
Updated: 3/3/2016
Click here to add this to my saved trials
Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Clinical Trial
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling,
Phase
II
Updated: 3/3/2016
Click here to add this to my saved trials
Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Clinical Trial
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling,
Phase
II
Updated: 3/3/2016
Click here to add this to my saved trials
Hypertension Clinical Trial
Treatment of Supine Hypertension in Autonomic Failure
Status: Enrolling,
Phase
I, II
Updated: 3/7/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology, Other Clinical Trial
Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Metabolic Effects of Angiotensin-(1-7)
Status: Enrolling,
Phase
Updated: 3/7/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of the ReCor Medical Paradise System in Clinical Hypertension
Status: Enrolling
Updated: 3/11/2016
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials
Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Pharmacokinetics of Sildenafil in Premature Infants
Status: Enrolling,
Phase
I
Updated: 3/17/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials
Hypertension, Portal Clinical Trial
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials
Hypertension, Portal Clinical Trial
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials
Hypertension, Portal Clinical Trial
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials
Hypertension, Portal Clinical Trial
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials
Hypertension, Portal Clinical Trial
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials
Hypertension, Portal Clinical Trial
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials
Hypertension, Portal Clinical Trial
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials
Hypertension, Portal Clinical Trial
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials
Hypertension, Portal Clinical Trial
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials
Hypertension, Portal Clinical Trial
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials
Hypertension, Portal Clinical Trial
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials
Hypertension, Portal Clinical Trial
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Long Term Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension
Status: Enrolling,
Phase
II
Updated: 3/25/2016
Click here to add this to my saved trials
Persistent Pulmonary Hypertension Clinical Trial
PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling
Updated: 3/30/2016
Click here to add this to my saved trials
Persistent Pulmonary Hypertension Clinical Trial
PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling
Updated: 3/30/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated: 4/1/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
SPYRAL HTN-OFF MED Study
Status: Enrolling,
Phase
II
Updated: 4/1/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
SPYRAL HTN-OFF MED Study
Status: Enrolling,
Phase
II
Updated: 4/1/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
SPYRAL HTN-OFF MED Study
Status: Enrolling,
Phase
II
Updated: 4/1/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
SPYRAL HTN-OFF MED Study
Status: Enrolling,
Phase
II
Updated: 4/1/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
SPYRAL HTN-ON MED Study
Status: Enrolling,
Phase
II
Updated: 4/1/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
SPYRAL HTN-ON MED Study
Status: Enrolling,
Phase
II
Updated: 4/1/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
SPYRAL HTN-ON MED Study
Status: Enrolling,
Phase
II
Updated: 4/1/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
SPYRAL HTN-ON MED Study
Status: Enrolling,
Phase
II
Updated: 4/1/2016
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
Status: Enrolling,
Phase
I, II
Updated: 4/4/2016
Click here to add this to my saved trials
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Clinical Trial
Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling,
Phase
II
Updated: 4/4/2016
Click here to add this to my saved trials
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Clinical Trial
Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling,
Phase
II
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
New International CTEPH Database
Status: Enrolling
Updated: 4/5/2016
Click here to add this to my saved trials
Hypertension Clinical Trial
Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells
Status: Enrolling,
Phase
IV
Updated: 9/13/2013
Click here to add this to my saved trials
Pulmonary Hypertension Clinical Trial
Tadalafil for Sarcoidosis Associated Pulmonary Hypertension
Status: Enrolling,
Phase
II, III
Updated: 4/9/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Nebivolol and the Endothelin (ET)-1 System
Status: Enrolling,
Phase
IV
Updated: 12/2/2014
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Uncontrolled Hypertension Clinical Trial
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
II
Updated: 12/10/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
II
Updated: 12/10/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
II
Updated: 12/10/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
II
Updated: 12/10/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
II
Updated: 12/10/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
II
Updated: 12/10/2013
Click here to add this to my saved trials
We've found
2,627 High Blood Pressure (Hypertension)
clinical trials
Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/1/2016
The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study
Status: Enrolling,
Phase
IV
Updated: 3/1/2016
Click here to add this to my saved trials

Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/3/2016
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling,
Phase
II
Updated: 3/3/2016
Click here to add this to my saved trials

Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/3/2016
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling,
Phase
II
Updated: 3/3/2016
Click here to add this to my saved trials

Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/3/2016
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling,
Phase
II
Updated: 3/3/2016
Click here to add this to my saved trials

Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/3/2016
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling,
Phase
II
Updated: 3/3/2016
Click here to add this to my saved trials

Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/3/2016
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling,
Phase
II
Updated: 3/3/2016
Click here to add this to my saved trials

Hypertension Clinical Trial
Updated: 3/7/2016
Treatment of Supine Hypertension in Autonomic Failure
Status: Enrolling,
Phase
I, II
Updated: 3/7/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Neurology, Other Clinical Trial
Updated: 3/7/2016
Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 3/7/2016
Metabolic Effects of Angiotensin-(1-7)
Status: Enrolling,
Phase
Updated: 3/7/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 3/11/2016
A Study of the ReCor Medical Paradise System in Clinical Hypertension
Status: Enrolling
Updated: 3/11/2016
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/17/2016
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/17/2016
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/17/2016
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/17/2016
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/17/2016
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/17/2016
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/17/2016
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/17/2016
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/17/2016
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/17/2016
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/17/2016
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/17/2016
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/17/2016
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials

Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Updated: 3/17/2016
Pharmacokinetics of Sildenafil in Premature Infants
Status: Enrolling,
Phase
I
Updated: 3/17/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 3/18/2016
Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/23/2016
Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/23/2016
Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/23/2016
Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials

Hypertension, Portal Clinical Trial
Updated: 3/24/2016
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials

Hypertension, Portal Clinical Trial
Updated: 3/24/2016
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials

Hypertension, Portal Clinical Trial
Updated: 3/24/2016
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials

Hypertension, Portal Clinical Trial
Updated: 3/24/2016
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials

Hypertension, Portal Clinical Trial
Updated: 3/24/2016
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials

Hypertension, Portal Clinical Trial
Updated: 3/24/2016
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials

Hypertension, Portal Clinical Trial
Updated: 3/24/2016
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials

Hypertension, Portal Clinical Trial
Updated: 3/24/2016
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials

Hypertension, Portal Clinical Trial
Updated: 3/24/2016
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials

Hypertension, Portal Clinical Trial
Updated: 3/24/2016
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials

Hypertension, Portal Clinical Trial
Updated: 3/24/2016
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials

Hypertension, Portal Clinical Trial
Updated: 3/24/2016
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 3/25/2016
Long Term Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension
Status: Enrolling,
Phase
II
Updated: 3/25/2016
Click here to add this to my saved trials

Persistent Pulmonary Hypertension Clinical Trial
Updated: 3/30/2016
PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling
Updated: 3/30/2016
Click here to add this to my saved trials

Persistent Pulmonary Hypertension Clinical Trial
Updated: 3/30/2016
PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling
Updated: 3/30/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 4/1/2016
Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated: 4/1/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 4/1/2016
SPYRAL HTN-OFF MED Study
Status: Enrolling,
Phase
II
Updated: 4/1/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 4/1/2016
SPYRAL HTN-OFF MED Study
Status: Enrolling,
Phase
II
Updated: 4/1/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 4/1/2016
SPYRAL HTN-OFF MED Study
Status: Enrolling,
Phase
II
Updated: 4/1/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 4/1/2016
SPYRAL HTN-OFF MED Study
Status: Enrolling,
Phase
II
Updated: 4/1/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 4/1/2016
SPYRAL HTN-ON MED Study
Status: Enrolling,
Phase
II
Updated: 4/1/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 4/1/2016
SPYRAL HTN-ON MED Study
Status: Enrolling,
Phase
II
Updated: 4/1/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 4/1/2016
SPYRAL HTN-ON MED Study
Status: Enrolling,
Phase
II
Updated: 4/1/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 4/1/2016
SPYRAL HTN-ON MED Study
Status: Enrolling,
Phase
II
Updated: 4/1/2016
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 4/4/2016
A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
Status: Enrolling,
Phase
I, II
Updated: 4/4/2016
Click here to add this to my saved trials

Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Clinical Trial
Updated: 4/4/2016
Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling,
Phase
II
Updated: 4/4/2016
Click here to add this to my saved trials

Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Clinical Trial
Updated: 4/4/2016
Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling,
Phase
II
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/4/2016
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/4/2016
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/4/2016
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/4/2016
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/4/2016
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/4/2016
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/4/2016
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/4/2016
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/4/2016
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/4/2016
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/4/2016
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/4/2016
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/4/2016
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/4/2016
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/4/2016
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/4/2016
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 4/5/2016
New International CTEPH Database
Status: Enrolling
Updated: 4/5/2016
Click here to add this to my saved trials

Hypertension Clinical Trial
Updated: 9/13/2013
Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells
Status: Enrolling,
Phase
IV
Updated: 9/13/2013
Click here to add this to my saved trials

Pulmonary Hypertension Clinical Trial
Updated: 4/9/2013
Tadalafil for Sarcoidosis Associated Pulmonary Hypertension
Status: Enrolling,
Phase
II, III
Updated: 4/9/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/2/2014
Nebivolol and the Endothelin (ET)-1 System
Status: Enrolling,
Phase
IV
Updated: 12/2/2014
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Uncontrolled Hypertension Clinical Trial
Updated: 5/2/2013
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/10/2013
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
II
Updated: 12/10/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/10/2013
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
II
Updated: 12/10/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/10/2013
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
II
Updated: 12/10/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/10/2013
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
II
Updated: 12/10/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/10/2013
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
II
Updated: 12/10/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/10/2013
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
II
Updated: 12/10/2013
Click here to add this to my saved trials
